2023年美国结肠癌、直肠癌统计数据解读及中国预防管理现状

doi:10.3969/j.issn.1006-5253.2024.03.014

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (3187 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Colorectal Cancer (CRC) statistics are updated by American Cancer Society every 3 years based on morbidity provided by the population cancer registry and mortality provided by the National Center for Health Statistics. In 2023, about 153 020 people will be diagnosed with CRC and 52 550 will die from the disease, including 19 550 cases and 3 750 deaths among people under 50 years old. The magnitude of the decline in CRC incidence has changed, from 3%4% per year in 20002010 to 1% per year in 20112019. The proportion of rectal cancer increased from 27% in 1995 to 31% in 2019, and CRC incidence was migrating to the left colon. From 2011 to 2020, CRC mortality overall decreased by 2% per year, but CRC mortality increased by 0.5%3.0% per year in the native Americans under 50 years old and under 65 years old. In summary, despite the continual decline in overall mortality, CRC is rapidly shifting towards younger, more advanced stages and development in the left colon/rectum. In this paper, the important contents of the updated data are sorted out and briefly interpreted. At the same time, compared with the present situation of CRC in our country, we can reveal and analyze the cause of the rising incidence of CRC to provide reference for CRC diagnosis and treatment.

Key words： colon cancer rectal cancer early colorectal cancer epidemiology screening

Received: 13 September 2023

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Su Guoqiang
	Zhou Xin
	Lü You

Cite this article:

Su Guoqiang,Zhou Xin,Lü You. Interpretation of colon cancer and rectal cancer statistics in the United States in 2023 and current status of preventive management in China[J]. journal1, 2024, 31(3): 230-235.

URL:

http://manu58.magtech.com.cn/Jwk_zgyytj/EN/10.3969/j.issn.1006-5253.2024.03.014 OR http://manu58.magtech.com.cn/Jwk_zgyytj/EN/Y2024/V31/I3/230

［1］SIEGEL R, WAGLE N S, CERCEK A, et al. Colorectal cancer statistics, 2023［J］. CA A Cancer J Clin, 2023,73(3):233-254. DOI: 10.3322/caac.21772.

［2］WINAWER S J, ZAUBER A G. The advanced adenoma as the primary target of screening［J］. Gastrointest Endosc Clin N Am, 2002,12(1):1-9. DOI: 10.1016/s1052-5157(03)00053-9.

［3］WOLF A M D, FONTHAM E T H, CHURCH T R, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society［J］. CA Cancer J Clin, 2018,68(4):250-281. DOI: 10.3322/caac.21457.

［4］WHITE A, IRONMONGER L, STEELE R J C, et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK［J］. BMC Cancer, 2018,18(1):906. DOI: 10.1186/s12885-018-4786-7.

［5］JACKSON S S, MARKS M A, KATKI H A, et al. Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors［J］. Cancer, 2022,128(19):3531-3540. DOI: 10.1002/cncr.34390.

［6］NISHIHARA R, WU K N, LOCHHEAD P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy［J］. N Engl J Med, 2013,369(12):1095-1105. DOI: 10.1056/NEJMoa1301969.

［7］DOLL R. Progress against cancer: An epidemiologic assessment. the 1991 john C. cassel memorial lecture［J］. Am J Epidemiol, 1991,134(7):675-688. DOI: 10.1093/oxfordjournals.aje.a116143.

［8］DOUBENI C A, CORLEY D A, QUINN V P, et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: A large community-based study［J］. Gut, 2018,67(2):291-298. DOI: 10.1136/gutjnl-2016-312712.

［9］XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022:Profiles, trends, and determinants［J］. Chin Med J, 2022,135(5):584-590. DOI: 10.1097/CM9.0000000000002108.

［10］樊代明.中国肿瘤整合诊治指南［M］.天津:天津科学技术出版社,2022.

［11］SIEGEL R L, MILLER K D, GODING SAUER A, et al. Colorectal cancer statistics, 2020［J］. CA Cancer J Clin, 2020,70(3):145-164. DOI: 10.3322/caac.21601.

［12］CHEN R, LIU Y, SONG G H, et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: A multicentre population-based cohort study［J］. Gut, 2021,70(2):251-260. DOI: 10.1136/gutjnl-2019-320200.

［13］BOSCH S L, TEERENSTRA S, DE WILT J H W, et al. Predicting lymph node metastasis in PT1 colorectal cancer: A systematic review of risk factors providing rationale for therapy decisions［J］. Endoscopy, 2013,45(10):827-834. DOI: 10.1055/s-0033-1344238.